PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+35.59%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$9.28B
AUM Growth
+$9.28B
(+37%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
12.62%
Top 10 Holdings %
Top 10 Hldgs %
43.31%
Holding
162
New
36
Increased
23
Reduced
15
Closed
21
Top Buys
| 1 |
NVTA
Invitae Corporation
NVTA
|
$305M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$226M |
| 3 |
Atea Pharmaceuticals
AVIR
|
$130M |
| 4 |
C4 Therapeutics
CCCC
|
$105M |
| 5 |
KRON
Kronos Bio
KRON
|
$83M |
Top Sells
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$190M |
| 2 |
CRISPR Therapeutics
CRSP
|
$112M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
$77.6M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$61.6M |
| 5 |
Cogent Biosciences
COGT
|
$53.5M |
Sector Composition
| 1 | Healthcare | 85.79% |
| 2 | Industrials | 0.29% |
| 3 | Materials | 0.22% |
| 4 | Financials | 0.13% |
| 5 | Consumer Discretionary | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $811M | 8.71% | 3,693,516 +257,941 | +8% | +$56.7M |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $580M | 6.22% | 25,112,048 -10,000 | -0% | -$231K |
|
3
BridgeBio Pharma
BBIO
$9.89B
| $477M | 5.12% | 6,706,268 | – | – |
|
4
Iovance Biotherapeutics
IOVA
$807M
| $425M | 4.56% | 9,166,304 -919,328 | -9% | -$42.7M |
|
|
NVTA
5
DELISTED
Invitae Corporation
NVTA
| $305M | 3.27% | +7,284,466 | New | +$305M |
|
|
SWTX
6
DELISTED
SpringWorks Therapeutics
SWTX
| $303M | 3.25% | 4,177,721 +696,573 | +20% | +$50.5M |
|
|
GBT
7
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $246M | 2.64% | 5,674,711 -126,285 | -2% | -$5.47M |
|
|
HZNP
8
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $226M | 2.42% | +3,084,042 | New | +$226M |
|
9
Zymeworks
ZYME
$1.12B
| $203M | 2.18% | 4,300,999 -100,000 | -2% | -$4.73M |
|
10
Rocket Pharmaceuticals
RCKT
$354M
| $186M | 2% | 3,396,867 +1,207,857 | +55% | +$66.2M |
|
11
Neurocrine Biosciences
NBIX
$13.8B
| $182M | 1.95% | 1,899,215 +350,500 | +23% | +$33.6M |
|
|
NVRO
12
DELISTED
NEVRO CORP.
NVRO
| $169M | 1.82% | 977,565 +151,401 | +18% | +$26.2M |
|
13
Outset Medical
OM
$247M
| $162M | 1.74% | 2,847,822 | – | – |
|
|
VBIV
14
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $151M | 1.62% | 55,042,465 | – | – |
|
|
ATNX
15
DELISTED
Athenex, Inc. Common Stock
ATNX
| $150M | 1.61% | 13,532,467 | – | – |
|
|
16
Atea Pharmaceuticals
AVIR
$267M
| $130M | 1.39% | +3,109,224 | New | +$130M |
|
17
Novavax
NVAX
$1.21B
| $116M | 1.25% | 1,043,000 +335,285 | +47% | +$37.4M |
|
18
Korro Bio
KRRO
$217M
| $115M | 1.23% | 3,259,635 +3,117 | +0.1% | +$110K |
|
19
Kodiak Sciences
KOD
$478M
| $110M | 1.18% | 751,533 -291,488 | -28% | -$42.8M |
|
20
Athira Pharma
ATHA
$15.3M
| $107M | 1.14% | 3,114,805 | – | – |
|
21
MeiraGTx Holdings
MGTX
$587M
| $105M | 1.13% | 6,933,277 +500,000 | +8% | +$7.57M |
|
|
22
C4 Therapeutics
CCCC
$185M
| $105M | 1.12% | +3,158,566 | New | +$105M |
|
23
Relay Therapeutics
RLAY
$619M
| $96.8M | 1.04% | 2,329,407 | – | – |
|
24
Travere Therapeutics
TVTX
$1.56B
| $95.2M | 1.02% | 3,493,607 +253,495 | +8% | +$6.91M |
|
|
EIDX
25
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $90.4M | 0.97% | 686,922 | – | – |
|